Zobrazeno 1 - 10
of 770
pro vyhledávání: '"Loeliger, E."'
Autor:
Tricou V; Takeda Pharmaceuticals International AG, 8152 Glattpark-Opfikon (Zurich), Switzerland. Electronic address: vianney.tricou@takeda.com., Eyre S; Medical Operations, Synexus Merseyside Clinical Research Centre, Liverpool, L22 0LG Merseyside, UK., Ramjee M; Synexus Lancashire Clinical Research Centre, Chorley, PR7 7NA Lancashire, UK., Collini P; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, S10 2RX Sheffield, UK., Mojares Z; Takeda Pharmaceuticals International AG, 8152 Glattpark-Opfikon (Zurich), Switzerland., Loeliger E; Takeda Pharmaceuticals International AG, 8152 Glattpark-Opfikon (Zurich), Switzerland., Mandaric S; Takeda Pharmaceuticals International AG, 8152 Glattpark-Opfikon (Zurich), Switzerland., Rauscher M; Takeda Pharmaceuticals International AG, 8152 Glattpark-Opfikon (Zurich), Switzerland., Brose M; Takeda Pharmaceuticals International AG, 8152 Glattpark-Opfikon (Zurich), Switzerland., Lefevre I; Takeda Pharmaceuticals International AG, 8152 Glattpark-Opfikon (Zurich), Switzerland., Folschweiller N; Takeda Pharmaceuticals International AG, 8152 Glattpark-Opfikon (Zurich), Switzerland., Wallace D; Global Dengue Program, Takeda Vaccines, Inc., Boston, 02139 MA, USA.
Publikováno v:
Vaccine [Vaccine] 2023 Feb 10; Vol. 41 (7), pp. 1398-1407. Date of Electronic Publication: 2023 Jan 19.
Autor:
Valentin A; Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD, United States., Bergamaschi C; Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD, United States., Rosati M; Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD, United States., Angel M; Vaccine Branch, Center for Cancer Research, National Cncer Institute, Bethesda, MD, United States.; Center for Cancer Research Collaborative Bioinformatics Resource, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, United States., Burns R; Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD, United States., Agarwal M; Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD, United States., Gergen J; CureVac AG, Tübingen, Germany., Petsch B; CureVac AG, Tübingen, Germany., Oostvogels L; CureVac AG, Tübingen, Germany., Loeliger E; CureVac AG, Tübingen, Germany., Chew KW; Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA, United States., Deeks SG; Division of HIV, Infectious Diseases and Global Medicine, University of California, San Francisco, CA, United States., Mullins JI; Department of Microbiology, University of Washington, Seattle, WA, United States.; Department of Medicine, University of Washington, Seattle, WA, United States.; Department of Global Health, University of Washington, Seattle, WA, United States., Pavlakis GN; Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD, United States., Felber BK; Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 Jul 22; Vol. 13, pp. 945706. Date of Electronic Publication: 2022 Jul 22 (Print Publication: 2022).
Publikováno v:
British Medical Journal (Clinical Research Edition), 1985 Aug 01. 291(6491), 352-352.
Externí odkaz:
https://www.jstor.org/stable/29520144
Publikováno v:
British Medical Journal (Clinical Research Edition), 1982 May 01. 284(6325), 1330-1331.
Externí odkaz:
https://www.jstor.org/stable/29506293
Publikováno v:
British Medical Journal (Clinical Research Edition), 1984 Feb 01. 288(6415), 486-487.
Externí odkaz:
https://www.jstor.org/stable/29514058
Publikováno v:
The British Medical Journal, 1969 May . 2(5654), 445-445.
Externí odkaz:
https://www.jstor.org/stable/20376425
Autor:
Loeliger, E. A.
Publikováno v:
The British Medical Journal, 1970 May 01. 2(5704), 300-300.
Externí odkaz:
https://www.jstor.org/stable/20383604
Autor:
Wang, Lingli1,2,3,4 (AUTHOR), Wan, Jiawu1,2,3,4 (AUTHOR), He, Wenna1,2,3,4 (AUTHOR), Wang, Zongmei1,2,3,4 (AUTHOR), Wu, Qiong1,2,3,4 (AUTHOR), Zhou, Ming1,2,3,4 (AUTHOR), Fu, Zhen F.1,2,3,4 (AUTHOR), Zhao, Ling1,2,3,4 (AUTHOR) zling604@outlook.com
Publikováno v:
Journal of Nanobiotechnology. 11/16/2024, Vol. 22 Issue 1, p1-19. 19p.
Autor:
de Souza Cardoso, Ricardo1 (AUTHOR) rdsc@umich.edu, Ono, Akira1 (AUTHOR) akiraono@umich.edu
Publikováno v:
Viruses (1999-4915). Nov2024, Vol. 16 Issue 11, p1714. 21p.
Autor:
Herrmann, Dominik1 (AUTHOR) dominik.herrmann@regeneron.com, Meng, Shuyu2,3 (AUTHOR) meng0137@umn.edu, Yang, Huixin2 (AUTHOR) yang5928@umn.edu, Mansky, Louis M.2,3,4,5,6 (AUTHOR) mansky@umn.edu, Saad, Jamil S.1 (AUTHOR) saad@uab.edu
Publikováno v:
Viruses (1999-4915). Oct2024, Vol. 16 Issue 10, p1528. 25p.